Drug factory · FDA FEI 3003387535

LTS Lohmann Therapie-Systeme AG

Lohmann Strasse 2, Andernach, Germany

Germany: 1

No problems found at FDA's last inspection, May 18, 2022.

No Action Indicated: inspectors found no objectionable conditions.

6 drug inspections on record since 2009: 3 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
BuprenorphineMakes it Rhodes Pharmaceuticals L.P. 42858-353, 42858-493, 42858-586 +2
CapsaicinMakes it Averitas Pharma, Inc. 72512-928, 72512-929, 72512-930
ScopolamineMakes it Rhodes Pharmaceuticals L.P. 42858-150

FDA inspection history

EndedResultProgramProblems noted
May 18, 2022No problems foundDrug Quality Assurance—
Oct 31, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 15, 2017Problems found, fixed voluntarilyDrug Quality Assurance3
Dec 20, 2013No problems foundDrug Quality Assurance—
Jun 21, 2011Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 18, 2009No problems foundDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Sep 15, 2017 inspection

Registered with FDA for: analysis; manufacture; pack.